Rolf Ramelmeier was Appointed as Chief Technology Officer at Adverum

Date of management change: August 21, 2023 

What Happened?

Redwood City, CA-based Adverum Appointed Rolf Ramelmeier as Chief Technology Officer

 

About the Company

Adverum Biotechnologies (Nasdaq: ADVM) is a clinical-stage gene therapy company targeting unmet medical needs for serious ocular and rare diseases. Adverum is evaluating its novel gene therapy candidate, ADVM-022, as a one-time, intravitreal injection for the treatment of its lead indication, wet age-related macular degeneration.

 

About the Person

Rolf Ramelmeier is Chief Technology Officer at Adverum. Previously, Rolf held various senior IT leadership roles in the industry.

 

Info Source

News

 

imageShort Profile

 

Name: Rolf Ramelmeier

Title: Chief Technology Officer

Company: Adverum

Industry: Biotechnology

imageCurrent Contact Info

 

Email: ***********@adverum.com 

Phone:.***.***.*32* 

To get full contact details, please sign in or

 
Your email is safe with us: see our privacy policy
 

Other IT executives who recently changed jobs as well: Brooks Marc, Palmer David, Lovan Shea, Hansen Nathan, Lutz Samuel, Wake Steve, Miguel Sobron Jose, Solomon Priscilla, Burton Bill, Fowler Mark, Gentry Craig

You can find the full directory of IT executives here.

How would you like to connect with 15,000+ IT executives in charge of $ millions in IT budgets? Find details here.